These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29106314)

  • 1. Protein biomarkers in renal transplantation.
    Chakraborty A; Sarwal M
    Expert Rev Proteomics; 2018 Jan; 15(1):41-54. PubMed ID: 29106314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics for Biomarker Identification and Clinical Application in Kidney Disease.
    Chen L; Su W; Chen H; Chen DQ; Wang M; Guo Y; Zhao YY
    Adv Clin Chem; 2018; 85():91-113. PubMed ID: 29655463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new method for classifying different phenotypes of kidney transplantation.
    Zhu D; Liu Z; Pan Z; Qian M; Wang L; Zhu T; Xue Y; Wu D
    Cell Biol Toxicol; 2016 Aug; 32(4):323-32. PubMed ID: 27278387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proteomic profiling of renal tissue in human chronic rejection biopsy samples after renal transplantation.
    Lin XC; Sui WG; Qi SW; Tang DE; Cong S; Zou GM; Zhang Y; Li H; Chen WB; Cheng ZQ; Dai Y
    Transplant Proc; 2015 Mar; 47(2):323-31. PubMed ID: 25769567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal transplant rejection markers.
    Gwinner W
    World J Urol; 2007 Oct; 25(5):445-55. PubMed ID: 17786452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel multivariate methods for integration of genomics and proteomics data: applications in a kidney transplant rejection study.
    Günther OP; Shin H; Ng RT; McMaster WR; McManus BM; Keown PA; Tebbutt SJ; Lê Cao KA
    OMICS; 2014 Nov; 18(11):682-95. PubMed ID: 25387159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Genomics and Pathway Analysis in Our Understanding and Prediction of Clinical Renal Transplant Injury.
    Menon MC; Keung KL; Murphy B; OʼConnell PJ
    Transplantation; 2016 Jul; 100(7):1405-14. PubMed ID: 26447506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers in Transplantation--Proteomics and Metabolomics.
    Christians U; Klawitter J; Klawitter J
    Ther Drug Monit; 2016 Apr; 38 Suppl 1(Suppl 1):S70-4. PubMed ID: 26418702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic research in renal transplantation.
    Clarke W
    Ther Drug Monit; 2006 Feb; 28(1):19-22. PubMed ID: 16418688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary proteomics to diagnose chronic active antibody-mediated rejection in pediatric kidney transplantation - a pilot study.
    Kanzelmeyer NK; Zürbig P; Mischak H; Metzger J; Fichtner A; Ruszai KH; Seemann T; Hansen M; Wygoda S; Krupka K; Tönshoff B; Melk A; Pape L
    Transpl Int; 2019 Jan; 32(1):28-37. PubMed ID: 30357927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine proteomic profiling for biomarkers of acute renal transplant rejection.
    Liang SL; Clarke W
    Methods Mol Biol; 2010; 641():185-91. PubMed ID: 20407948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics: a complementary tool in renal transplantation.
    Wishart DS
    Contrib Nephrol; 2008; 160():76-87. PubMed ID: 18401163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of acute renal allograft rejection by analysis of renal tissue proteomics in rat models of renal transplantation.
    Dai Y; Lv T; Wang K; Huang Y; Li D; Liu J
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):952-9. PubMed ID: 18974583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New developments in transplant proteomics.
    Ho J; Hirt-Minkowski P; Wilkins JA
    Curr Opin Nephrol Hypertens; 2017 May; 26(3):229-234. PubMed ID: 28221173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer biomarker discovery and translation: proteomics and beyond.
    Hristova VA; Chan DW
    Expert Rev Proteomics; 2019 Feb; 16(2):93-103. PubMed ID: 30556752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mining the human urine proteome for monitoring renal transplant injury.
    Sigdel TK; Gao Y; He J; Wang A; Nicora CD; Fillmore TL; Shi T; Webb-Robertson BJ; Smith RD; Qian WJ; Salvatierra O; Camp DG; Sarwal MM
    Kidney Int; 2016 Jun; 89(6):1244-52. PubMed ID: 27165815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A computational pipeline for the development of multi-marker bio-signature panels and ensemble classifiers.
    Günther OP; Chen V; Freue GC; Balshaw RF; Tebbutt SJ; Hollander Z; Takhar M; McMaster WR; McManus BM; Keown PA; Ng RT
    BMC Bioinformatics; 2012 Dec; 13():326. PubMed ID: 23216969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Noninvasive diagnostic and predictive value in renal transplant recipients with acute rejection by measurement of urine Fractalkine].
    Chen DJ; Peng WH; Jiang H; Huang HF; Wu JY; Wang HP; Chen JH
    Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(2):92-98. PubMed ID: 28088951
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevated Urinary Matrix Metalloproteinase-7 Detects Underlying Renal Allograft Inflammation and Injury.
    Ho J; Rush DN; Krokhin O; Antonovici M; Gao A; Bestland J; Wiebe C; Hiebert B; Rigatto C; Gibson IW; Wilkins JA; Nickerson PW
    Transplantation; 2016 Mar; 100(3):648-54. PubMed ID: 26906940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The early diagnosis of acute renal graft dysfunction: a challenge we face. The role of novel biomarkers.
    Halawa A
    Ann Transplant; 2011; 16(1):90-8. PubMed ID: 21436782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.